These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 2885642)
1. Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever. Clegg JC; Lloyd G Lancet; 1987 Jul; 2(8552):186-8. PubMed ID: 2885642 [TBL] [Abstract][Full Text] [Related]
2. Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus. Morrison HG; Bauer SP; Lange JV; Esposito JJ; McCormick JB; Auperin DD Virology; 1989 Jul; 171(1):179-88. PubMed ID: 2741340 [TBL] [Abstract][Full Text] [Related]
3. Mucosal immunization with Salmonella typhimurium expressing Lassa virus nucleocapsid protein cross-protects mice from lethal challenge with lymphocytic choriomeningitis virus. Djavani M; Yin C; Lukashevich IS; Rodas J; Rai SK; Salvato MS J Hum Virol; 2001; 4(2):103-8. PubMed ID: 11437313 [TBL] [Abstract][Full Text] [Related]
4. Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infection. Auperin DD; Esposito JJ; Lange JV; Bauer SP; Knight J; Sasso DR; McCormick JB Virus Res; 1988 Feb; 9(2-3):233-48. PubMed ID: 3354260 [TBL] [Abstract][Full Text] [Related]
5. A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene. Cai Y; Ye C; Cheng B; Nogales A; Iwasaki M; Yu S; Cooper K; Liu DX; Hart R; Adams R; Brady T; Postnikova EN; Kurtz J; St Claire M; Kuhn JH; de la Torre JC; Martínez-Sobrido L mBio; 2020 Feb; 11(1):. PubMed ID: 32098811 [TBL] [Abstract][Full Text] [Related]
6. DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs. Cashman KA; Wilkinson ER; Wollen SE; Shamblin JD; Zelko JM; Bearss JJ; Zeng X; Broderick KE; Schmaljohn CS Hum Vaccin Immunother; 2017 Dec; 13(12):3010-3019. PubMed ID: 29135337 [TBL] [Abstract][Full Text] [Related]
7. Towards a human Lassa fever vaccine. Fisher-Hoch SP; McCormick JB Rev Med Virol; 2001; 11(5):331-41. PubMed ID: 11590670 [TBL] [Abstract][Full Text] [Related]
8. A Lassa Virus Live-Attenuated Vaccine Candidate Based on Rearrangement of the Intergenic Region. Cai Y; Iwasaki M; Motooka D; Liu DX; Yu S; Cooper K; Hart R; Adams R; Burdette T; Postnikova EN; Kurtz J; St Claire M; Ye C; Kuhn JH; Martínez-Sobrido L; de la Torre JC mBio; 2020 Mar; 11(2):. PubMed ID: 32209677 [TBL] [Abstract][Full Text] [Related]
9. [The localization and preliminary characteristics of antigenic sites (B epitopes) in the nucleocapsid protein of the Lassa virus]. Vladyko AS; Bystrova SI; Malakhova IV; Kunitskaia LIa; Lemeshko NN; Kras'ko AG; Kozhich AT; Lukashevich IS Vopr Virusol; 1993; 38(1):30-4. PubMed ID: 7521097 [TBL] [Abstract][Full Text] [Related]
10. A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses. Safronetz D; Mire C; Rosenke K; Feldmann F; Haddock E; Geisbert T; Feldmann H PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003736. PubMed ID: 25884628 [TBL] [Abstract][Full Text] [Related]
11. A vaccine based on recombinant modified Vaccinia Ankara containing the nucleoprotein from Lassa virus protects against disease progression in a guinea pig model. Kennedy EM; Dowall SD; Salguero FJ; Yeates P; Aram M; Hewson R Vaccine; 2019 Aug; 37(36):5404-5413. PubMed ID: 31331770 [TBL] [Abstract][Full Text] [Related]
12. Expression of the Lassa virus nucleocapsid protein in insect cells infected with a recombinant baculovirus: application to diagnostic assays for Lassa virus infection. Barber GN; Clegg JC; Lloyd G J Gen Virol; 1990 Jan; 71 ( Pt 1)():19-28. PubMed ID: 2406367 [TBL] [Abstract][Full Text] [Related]
13. Possible approaches to a vaccine against Lassa fever. Clegg JC Trans R Soc Trop Med Hyg; 1984; 78(3):307-10. PubMed ID: 6464128 [No Abstract] [Full Text] [Related]
14. [Use of guinea pigs for assessing the efficacy of vaccines against Lassa fever]. Firsova IV; Shatokhina IV; Borisevich IV; Evseev AA; Maksimov VA; Pantiukhov VB; Khmelev AL Vopr Virusol; 2003; 48(6):43-5. PubMed ID: 14708232 [TBL] [Abstract][Full Text] [Related]
15. A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity. Carrion R; Patterson JL; Johnson C; Gonzales M; Moreira CR; Ticer A; Brasky K; Hubbard GB; Moshkoff D; Zapata J; Salvato MS; Lukashevich IS Vaccine; 2007 May; 25(20):4093-102. PubMed ID: 17360080 [TBL] [Abstract][Full Text] [Related]